Militia Capital Partners LP Buys Shares of 35,000 IMAX Corporation $IMAX

Key Points

• Militia Capital Partners opened a new position in IMAX during the fourth quarter, buying 35,000 shares worth about $1.29 million and giving it roughly 0.07% ownership.
• IMAX continues to see heavy institutional and insider activity: institutions own 93.51% of the stock, while CEO Richard L. Gelfond recently sold 8,943 shares in a pre-arranged trading plan.
• The stock has been supported by strong business momentum, with IMAX reporting better-than-expected quarterly EPS and revenue and analysts maintaining a generally bullish outlook, including a consensus Moderate Buy rating and $48 average target price.

Militia Capital Partners LP purchased a new stake in shares of IMAX Corporation (NYSE:IMAX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 35,000 shares of the company's stock, valued at approximately $1,294,000. Militia Capital Partners LP owned approximately 0.07% of IMAX at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Divisadero Street Capital Management LP acquired a new stake in shares of IMAX during the 3rd quarter valued at approximately $20,975,000. Principal Financial Group Inc. grew its stake in shares of IMAX by 67.8% in the third quarter. Principal Financial Group Inc. now owns 70,927 shares of the company's stock worth $2,323,000 after purchasing an additional 28,667 shares in the last quarter. Citigroup Inc. grew its stake in shares of IMAX by 267.7% in the third quarter. Citigroup Inc. now owns 66,769 shares of the company's stock worth $2,187,000 after purchasing an additional 48,609 shares in the last quarter. Hedges Asset Management LLC bought a new position in shares of IMAX in the fourth quarter worth $2,088,000. Finally, Zhang Financial LLC bought a new position in IMAX during the third quarter valued at about $903,000. 93.51% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at IMAX

In other news, CEO Richard L. Gelfond sold 8,943 shares of the firm's stock in a transaction dated Monday, April 27th. The stock was sold at an average price of $37.33, for a total transaction of $333,842.19. Following the completion of the sale, the chief executive officer directly owned 765,002 shares of the company's stock, valued at $28,557,524.66. This trade represents a 1.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 365,064 shares of company stock worth $13,719,850. 20.55% of the stock is owned by company insiders.

Key Headlines Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX shares hit a 52-week high as strong summer box office performance and improving investor confidence continue to lift sentiment around the company’s business model. IMAX stock near record high as summer box office momentum builds
• Positive Sentiment: Christopher Nolan’s The Odyssey broke BFI IMAX ticket-sale records, highlighting demand for IMAX’s premium presentation for event films. The Odyssey Breaks BFI IMAX 24-Hour Ticket Sale Record
• Positive Sentiment: Additional coverage of The Odyssey breaking IMAX records reinforces the idea that blockbuster releases can drive stronger ticket demand and utilization for IMAX screens. Christopher Nolan's 'The Odyssey' breaks BFI Imax records
• Positive Sentiment: Coverage highlighting “3 Big Reasons to Love IMAX” adds to bullish retail and media attention around the stock. 3 Big Reasons to Love IMAX (IMAX)
• Neutral Sentiment: Several articles about IMAX-enhanced viewing, theater expansions, and comparisons with competing formats reflect ongoing brand visibility, but do not directly change IMAX’s financial outlook. IMAX Enhanced doesn't do what you think it does on your TV
• Neutral Sentiment: New IMAX and ScreenX installations in places like Petaluma and Northeast Ohio suggest continued theater adoption, but these updates are incremental rather than a major earnings catalyst. Petaluma’s only cinema adds IMAX and ScreenX theaters
• Neutral Sentiment: Reports that Spider-Man: Brand New Day will not be released in IMAX in India may matter locally, but the broader market impact appears limited. Spider-Man: Brand new day will not be released in IMAX in India
• Neutral Sentiment: Explainer content on Dolby Cinema versus IMAX is informational and unlikely to move the stock on its own. What's the difference between Dolby Cinema and IMAX?

IMAX Trading Up 3.6%

Shares of IMAX stock opened at $43.85 on Wednesday. The stock has a 50-day moving average price of $37.57 and a 200 day moving average price of $37.35. The company has a market cap of $2.41 billion, a P/E ratio of 67.46, a P/E/G ratio of 1.50 and a beta of 0.37. IMAX Corporation has a 1 year low of $24.20 and a 1 year high of $44.55.

IMAX (NYSE:IMAX - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.02. IMAX had a return on equity of 13.61% and a net margin of 9.08%.The firm had revenue of $81.38 million during the quarter, compared to the consensus estimate of $79.82 million. During the same period in the prior year, the business earned $0.13 EPS. The business's revenue for the quarter was down 6.1% on a year-over-year basis. On average, equities analysts forecast that IMAX Corporation will post 1.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on IMAX shares. Keefe, Bruyette & Woods reaffirmed a "market perform" rating and set a $60.00 target price on shares of IMAX in a research note on Friday, May 22nd. Barrington Research raised their target price on IMAX from $42.00 to $46.00 and gave the company an "outperform" rating in a research note on Friday, May 1st. Wall Street Zen cut IMAX from a "buy" rating to a "hold" rating in a research note on Saturday, May 9th. JPMorgan Chase & Co. decreased their price target on IMAX from $48.00 to $47.00 and set an "overweight" rating for the company in a research report on Friday, May 1st. Finally, Seaport Research Partners increased their price target on IMAX from $43.00 to $45.00 and gave the company a "buy" rating in a research report on Wednesday, April 8th. Ten research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $48.00.

IMAX Company Profile

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.